Profusa (PFSA) Non Operating Income (2022 - 2026)
Profusa's (PFSA) quarterly Non Operating Income came in at $550000.0 in Q1 2026, up 142.57% year-on-year from $226739.0 in Q1 2025, and up 150.05% quarter-over-quarter from -$1.1 million in Q4 2025.
Profusa (PFSA) Non Operating Income (2022 - 2026) Analysis & Trends
Profusa's Non Operating Income history runs 5 years deep, the most recent figure standing at $550000.0 for Q1 2026.
- On a quarterly basis, Non Operating Income rose 142.57% year-over-year to $550000.0 in Q1 2026; TTM through Mar 2026 was -$8.3 million, a 107.66% decrease from a year earlier, with the FY2025 full-year figure at -$8.1 million, down 71.61% from the prior year.
- Non Operating Income rose to $550000.0 in Q1 2026 per PFSA's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $4.0 million in Q1 2022 and bottomed at -$7.2 million in Q2 2025.
- The 5-year median for Non Operating Income is -$51748.0 (2023), against an average of -$29401.9.
- Across the five-year window, Non Operating Income sank 5856.77% in 2025 and surged 142.57% in 2026, its largest moves.
- Year by year, Non Operating Income stood at $1.3 million in 2022, then tumbled by 45.24% to $722417.0 in 2023, then sank by 261.96% to -$1.2 million in 2024, then climbed by 6.07% to -$1.1 million in 2025, then jumped by 150.05% to $550000.0 in 2026.
- Per Business Quant, the three latest PFSA Non Operating Income figures stand at $550000.0 (Q1 2026), -$1.1 million (Q4 2025), and -$483000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 550,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 550,000.00 |
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | -483,000.00 |
| Jun 30, 2025 | -7.23 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Dec 31, 2024 | -1.17 Mn |
| Sep 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -121,331.00 |
| Mar 31, 2024 | -327,982.00 |
| Dec 31, 2023 | 722,417.00 |
| Sep 30, 2023 | -51,748.00 |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 2.21 Mn |
| Jun 30, 2022 | 1.46 Mn |
| Mar 31, 2022 | 3.95 Mn |